A carregar...
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
With the first cancer-targeted microRNA drug, MRX34, a liposome-based miR-34 mimic, entering phase I clinical trial in patients with advanced hepatocellular carcinoma in April 2013, miRNA therapeutics are attracting special attention from both academia and biotechnology companies. Although to date t...
Na minha lista:
| Publicado no: | Nat Rev Drug Discov |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548803/ https://ncbi.nlm.nih.gov/pubmed/24172333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd4140 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|